Use of angiotensin II antagonists in experimental hypertension.
D000804:Angiotensin II / Q000008:administration & dosage / Q000037:antagonists & inhibitors* / Q000494:pharmacology; D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D002476:Cellophane; D003250:Constriction; D004285:Dogs; D005260:Female; D006977:Hypertension, Renal / Q000188:drug therapy* / Q000209:etiology; D007275:Injections, Intravenous; D007532:Isoleucine / Q000008:administration & dosage / Q000494:pharmacology; D009392:Nephrectomy; D051381:Rats; D012077:Renal Artery; D012521:Sarcosine / Q000008:administration & dosage / Q000494:pharmacology; D013329:Structure-Activity Relationship
D007532:Isoleucine; D000804:Angiotensin II; D002476:Cellophane; D012521:Sarcosine